![Shawn McCormick](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shawn McCormick
Direktor/Vorstandsmitglied bei
NEVRO CORP.
Vermögen: 1 Mio $ am 31.05.2026
Profil
Shawn T.
McCormick is currently an Independent Director at Inspire Medical Systems, Inc. since 2017, an Independent Director at Nevro Corp.
since 2014, and an Advisor at Vensana Capital Management LLC since 2019.
Former roles include Independent Director at Surmodics, Inc. from 2015 to 2020, Independent Director at Entellus Medical, Inc. from 2014 to 2018, Director at Highridge Medical LLC from 2010 to 2013, Vice President-Corporate Development at Medtronic, Inc. from 2008 to 2009, Chief Financial Officer & Senior Vice President at ev3, Inc. from 2009 to 2010, Principal at KPMG Peat Marwick LLP, Chief Financial Officer at Tornier NV from 2012 to 2015, Chief Financial & Accounting Officer at Tornier, Inc. from 2012 to 2015, Chief Financial Officer at Wright Medical Group NV, Chief Financial Officer at Aldevron LLC from 2020 to 2022, and Chief Operating Officer at Lutonix, Inc. from 2011 to 2012.
Education includes undergraduate studies at Arizona State University and an MBA from The Curtis L.
Carlson School of Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.05.2026 | 30 712 ( 0,11 % ) | 1 Mio $ | 31.05.2026 |
Aktive Positionen von Shawn McCormick
| Unternehmen | Position | Beginn |
|---|---|---|
| NEVRO CORP. | Direktor/Vorstandsmitglied | 01.09.2014 |
| INSPIRE MEDICAL SYSTEMS, INC. | Direktor/Vorstandsmitglied | 01.01.2017 |
Vensana Capital Management LLC
 Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million. | Berater | 01.01.2019 |
Ehemalige bekannte Positionen von Shawn McCormick
| Unternehmen | Position | Ende |
|---|---|---|
Aldevron LLC
 Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Finanzdirektor/CFO | 01.02.2022 |
| SURMODICS | Direktor/Vorstandsmitglied | 15.12.2020 |
| ENTELLUS MEDICAL INC | Direktor/Vorstandsmitglied | 28.02.2018 |
Tornier NV
 Tornier NV Medical SpecialtiesHealth Technology Engages in the manufacturing and marketing of orthopedic reconstructive and other related products | Finanzdirektor/CFO | 01.10.2015 |
Tornier, Inc.
 Tornier, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services and distributes medical devices | Finanzdirektor/CFO | 01.10.2015 |
Ausbildung von Shawn McCormick
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
89
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Medtronic, Inc.
 Medtronic, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hypertension care | Health Technology |
Surmodics, Inc.
 Surmodics, Inc. Medical SpecialtiesHealth Technology Provides surface modification and in vitro diagnostic technology services to the healthcare industry | Health Technology |
ev3, Inc.
 ev3, Inc. Medical SpecialtiesHealth Technology Designs, manufactures and distributes medical devices | Health Technology |
Entellus Medical, Inc.
 Entellus Medical, Inc. Medical SpecialtiesHealth Technology Designs, develops and commercializes products for minimally invasive treatment of chronic sinusitis | Health Technology |
Lanx, Inc.
 Lanx, Inc. Medical SpecialtiesHealth Technology Develops medical devices for spinal surgery | Health Technology |
KPMG Peat Marwick LLP
 KPMG Peat Marwick LLP Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Aldevron LLC
Aldevron LLC BiotechnologyHealth Technology Manufactures and develops biological science products | Health Technology |
Arizona State University
 Arizona State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tornier NV
Tornier NV Medical SpecialtiesHealth Technology Engages in the manufacturing and marketing of orthopedic reconstructive and other related products | Health Technology |
Tornier, Inc.
Tornier, Inc. Hospital/Nursing ManagementHealth Services Provides healthcare services and distributes medical devices | Health Services |
Nevro Corp.
 Nevro Corp. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
Lutonix, Inc.
 Lutonix, Inc. Medical SpecialtiesHealth Technology Develops and commercializes drug coated balloon catheters | Health Technology |
Inspire Medical Systems, Inc.
 Inspire Medical Systems, Inc. Medical SpecialtiesHealth Technology Develops implantable neurostimulation systems to treat obstructive sleep apnea | Health Technology |
The Curtis L. Carlson School of Management
 The Curtis L. Carlson School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wright Medical Group NV
 Wright Medical Group NV Medical SpecialtiesHealth Technology Designs, manufactures and distributes orthopedic medical devices & biologic products | Health Technology |
Vensana Capital Management LLC
Vensana Capital Management LLC Investment ManagersFinance Vensana Capital invests in companies located across the globe, primarily in the United States. The firm focuses on companies operating in the field medical technology sector such as medical devices, life science tools & diagnostics, and data science & tech-enabled solutions. It provides financing for early and growth stage capital requirements with an investment size of USD 15 - 50 million. | Finance |
